Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 51.40
+0.80 (1.58%)
At close: May 25, 2026
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 13.85 billion as of May 22, 2026. Its market cap has decreased by -4.46% in one year.
Market Cap
13.85B
Enterprise Value
14.81B
Revenue
9.37B
Ranking
n/a
PE Ratio
18.29
Stock Price
51.40
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 13.85B, an increase of 1,996.88%. That is a compound annual growth rate of 10.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 13.63B | -18.12% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Sectra AB | 53.33B |
| Elekta AB | 23.15B |
| Vitrolife AB | 14.46B |
| Xvivo Perfusion AB | 9.27B |
| MedCap AB | 8.49B |
| CellaVision AB | 2.91B |
| Devyser Diagnostics AB | 1.62B |